Mark Charman

Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies

ER–lysosome contacts enable cholesterol sensing by mTORC1 and drive aberrant growth signalling in Niemann–Pick type C

Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis

Niemann-Pick disease type C

Recent insights on the role of cholesterol in non-alcoholic fatty liver disease

mTOR at the nexus of nutrition, growth, ageing and disease

The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)

Intracellular cholesterol transporters and modulation of hepatic lipid metabolism: Implications for diabetic dyslipidaemia and steatosis

Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks

Lipids on Trial: The Search for the Offending Metabolite in Niemann-Pick type C Disease

Defective cholesterol trafficking in Niemann‐Pick C‐deficient cells

Per- and Polyfluoroalkyl Substance Toxicity and Human Health Review: Current State of Knowledge and Strategies for Informing Future Research

Hepatitis C Virus Replication Depends on Endosomal Cholesterol Homeostasis

MLN64 mediates egress of cholesterol from endosomes to mitochondria in the absence of functional Niemann-Pick Type C1 protein

Oxysterol-binding Protein Activation at Endoplasmic Reticulum-Golgi Contact Sites Reorganizes Phosphatidylinositol 4-Phosphate Pools